Roche has agreed to acquire Spark Therapeutics for $4.8 billion cash, Spark said today, in a deal designed to expand the biopharma giant into gene therapy with the marketed Luxturna (voretigene neparvovec-rzyl) and a pipeline of other gene t... Read More >

Indiana University School of Medicine researchers have developed a test to measure pain pain in patients. The hope is that such a test could help in the fight against opioid abuse. The study was led by Alexander Niculescu, MD, PhD and was pu... Read More >

FDA published draft guidance on Feb. 25, 2019 on submission of bioavailability (BA) information for oral dosage drugs in investigation new drug applications (INDs), new drug applications (NDAs), and NDA supplements. In the guidance, FDA prov... Read More >

A multi-partner collaboration between Oxford Genetics, Sphere Fluidics, the University of Edinburgh, and Twist Bioscience has been announced, which will target the acceleration of the development of automated microfluidic systems for rapid a... Read More >

GE has agreed to sell its BioPharma business to Danaher Corporation for $21.4 billion, adding biopharmaceutical research, development, and manufacturing instruments, equipment, and consumables to Danahers Life Science group, which includes P... Read More >

C2N Diagnostics is experiencing a couple of breakthroughs with its Alzheimers disease detection test - one courtesy of FDA. The agency, which is slowly rising back to full strength after the temporary government shutdown, granted the St. Lou... Read More >

A newly-formed partnership between Biodesix and MRM Proteomics could be the key that unlocks the door for better outcomes in lung cancer patients. Earlier this week, the two diagnostic companies announced a deal that would have Montreal-base... Read More >

A new assay developed by researchers at Johns Hopkins University can accurately count the cells that comprise the HIV reservoir- one of the biggest obstacles in curing the disease. The development of the assay could help researchers who are... Read More >

Novodiag CarbaR+, a test for detecting carbapenemase-producing enterobacteriaceae (CPE) in just 80 minutes, has been issued CE Marking for an IVD. CPE are bacteria that are resistant to the carbapenem class of antibiotics, and early detectio... Read More >

Day Zero Diagnostics (DZD) is seeking to develop a more effective way of detecting infectious disease using artificial intelligence and genome sequencing. The Boston-based company announced it has raised $8.6 million in its mission to furthe... Read More >